• Oleic Acid Workflows for Lipid Metabolism Research

  2026-09-23

  Build reproducible hepatocyte lipid-loading models with Oleic Acid (C18:1(9Z)) while separating fatty-acid stress from pathway-specific rescue. This practical guide translates hepatic ischemia-reperfusion findings into dosing, controls, mechanistic readouts, and troubleshooting strategies.

• Thermal-Protective Hydrogel for Tumor Ablation

  2026-09-22

  The reference study introduces an injectable MR@CaP@HA hydrogel that combines local thermal insulation with pH- and glutathione-responsive delivery of mitoxantrone and Resiquimod. This integrated design addresses both incomplete ablation and weak post-ablation immunity, producing strong dendritic-cell and macrophage responses and complete tumor eradication in a subset of treated animals.

• Angiotensin 1/2 (5-7): Assay Design Guide

  2026-09-22

  Explore how Angiotensin 1/2 (5-7), the H2N-Ile-His-Pro-OH peptide, can support better-designed cardiovascular and receptor-binding studies. This guide emphasizes molecular identity, assay controls, evidence boundaries, and practical interpretation rather than repeating standard peptide protocols.

• Stable-Isotope UHPLC–MS/MS for Methylated Nucleosides

  2026-09-21

  The reference study introduces a stable isotope-diluted UHPLC–ESI-MS/MS workflow for sensitive, quantitative measurement of methylated purine nucleosides in cellular samples. Its combination of ammonium bicarbonate-assisted ionization, chromatographic isomer separation, and methanol–SPE cleanup addresses matrix suppression and supports intracellular nucleoside biomarker research.

• PP 3: A Better Control for ROS–Src Studies

  2026-09-21

  How PP 3 strengthens mechanistic interpretation in Src, NADPH oxidase, ROS, and vascular signaling experiments by separating kinase-dependent effects from L-type calcium-channel responses.

• Oleic Acid (C18:1(9Z)) Assay Workflow Guide

  2026-09-20

  Build controlled lipid-loading, signaling, inflammation, and cancer-cell assays with Oleic Acid rather than treating fatty-acid exposure as a single-variable experiment. This guide translates a hepatic ischemia-reperfusion model into practical dose design, mechanistic readouts, and troubleshooting decisions.

• Ionomycin free acid: Calcium Ionophore Workflows

  2026-09-19

  Build reproducible calcium ion transport, live-cell signaling, and oocyte activation assays with a controlled ionophore workflow. The guide also shows how to use calcium perturbation as an exploratory complement to the FAISL–FAK proteolysis model in triple-negative breast cancer research.

• Polybrene: Practical Guide to Viral Transduction

  2026-09-18

  Learn how Polybrene improves viral attachment, supports difficult lipid-mediated DNA transfection, and fits into controlled cell-engineering workflows. Practical titration, handling, and troubleshooting guidance helps balance delivery efficiency against cell-specific toxicity while clarifying what the FBXO22 degrader literature does—and does not—show.

• CGP 55845 hydrochloride: GABAB Assay Workflows

  2026-09-18

  Use CGP 55845 hydrochloride to separate GABAB receptor signaling from astrocytic GAT-3 activity in controlled neural assays. This workflow combines presynaptic pharmacology, electrophysiology, neurotransmitter release measurements, and troubleshooting guidance for more interpretable synaptic transmission research.

• EdU Flow Cytometry Assay Kits (Cy5) for S-Phase

  2026-09-17

  Measure active DNA synthesis without harsh denaturation using a bright Cy5 click-chemistry workflow. This guide translates the DCPS–epithelial proliferation findings in diabetic foot-ulcer research into practical assay design, controls, and troubleshooting strategies.

• Moxidectin: From Anthelmintic to Assay Modulator

  2026-09-17

  Moxidectin is best known as a macrocyclic lactone anthelmintic, but emerging evidence reveals a precise assay opportunity in polyene-based antifungal research. This article explains the ergosterol-centered mechanism, experimental decision points, formulation considerations, and the limits of translating veterinary antiparasitic evidence into oral candidiasis studies.

• Oleic Acid Assays: Reliable Lipid Models

  2026-09-16

  A scenario-driven guide to using Oleic Acid (SKU C4977) in viability, proliferation, cytotoxicity, and hepatocyte lipid-loading workflows. It connects formulation, solvent handling, pathway interpretation, and vendor selection to reproducible lipid metabolism research.

• Honokiol, Paraptosis, and MAPK Signaling in APL

  2026-09-16

  This study identifies honokiol-induced paraptosis-like death as a nonapoptotic response in NB4 acute promyelocytic leukemia cells and links it to proteasome impairment, endoplasmic reticulum stress, mTOR activity, and MAPK signaling. Its pharmacologic dissection provides a useful framework for interpreting MEK/ERK pathway inhibition, while also highlighting the limits of transferring findings from leukemia cells to neuronal or inflammatory models.

• BAP1 Regulation of Disulfidptosis

  2026-09-15

  A 2024 Oncogenesis study identifies BAP1 as a suppressor of glucose starvation-induced disulfidptosis through repression of SLC7A11-dependent cystine uptake and preservation of NADPH-linked reducing capacity. The findings clarify why the same BAP1–SLC7A11 axis can promote ferroptosis in one metabolic context while limiting disulfidptosis in another.

• Saracatinib (AZD0530): From Src Biology to Translation

  2026-09-15

  Saracatinib (AZD0530) offers a mechanistically grounded way to interrogate Src family kinase and Abl signaling across cancer models. This thought-leadership guide connects pathway biology, assay design, xenograft interpretation, and a carefully bounded neuroscience bridge to help translational researchers turn kinase inhibition into more informative experimental decisions.

8029 records 1/536 page Next 12345 下5页 Last page